 |
|
|
|
|
| |
|
|
| |
●
Founders
●
Scientific Advisory Board
●
Management |
Management
Constellation Pharmaceuticals’ Management and Board of
Directors: Unparalleled
scientific and business expertise dedicated to the
Company’s success in leveraging a new revolution in
biology, Epigenetics.
Our initial management team at Constellation is
comprised of individuals who have an outstanding and
proven track record of founding and building some of the
most respected and successful life sciences companies,
creating breakthrough science and delivering novel
therapeutics.
This interim team brings the full range of operating and
leadership experience across the critical disciplines --
science, technology, business development, marketing and
finance necessary build Constellation into a leading
biopharmaceutical company.
Constellation Pharmaceuticals’ Management
Mark Levin
Chief Executive Officer
Robert Tepper, M.D.
Chief Scientific Officer
Neil Exter
Chief Business Officer
Craig Muir
Chief Technology Officer
Constellation
Pharmaceuticals’ Board of Directors
Anthony Evnin
Partner, Venrock
David Goeddel
Partner, The Column Group
Mark Levin
Partner, Third Rock Ventures
Tom Maniatis
Professor, Harvard University
Bob Tepper
Partner, Third Rock Ventures
|
|
|
|
|
|